Rina Ulmansky

593 total citations
15 papers, 486 citations indexed

About

Rina Ulmansky is a scholar working on Immunology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rina Ulmansky has authored 15 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Rheumatology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rina Ulmansky's work include Systemic Lupus Erythematosus Research (9 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Cell Adhesion Molecules Research (4 papers). Rina Ulmansky is often cited by papers focused on Systemic Lupus Erythematosus Research (9 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Cell Adhesion Molecules Research (4 papers). Rina Ulmansky collaborates with scholars based in Israel and United States. Rina Ulmansky's co-authors include Yaakov Naparstek, Yechezkel Barenholz, Fanny Szafer, Eli Moallem, Simcha Even‐Chen, Cyril J. Cohen, Yechezkel Kashi, Zvi G. Fridlender, Galina Pizov and Moshe Baru and has published in prestigious journals such as The Journal of Immunology, Journal of Controlled Release and European Journal of Immunology.

In The Last Decade

Rina Ulmansky

15 papers receiving 468 citations

Peers

Rina Ulmansky
G. Vierwinden Netherlands
G L Costa United States
Kumiko Yanase United States
Christine M. Coquery United States
G. Vierwinden Netherlands
Rina Ulmansky
Citations per year, relative to Rina Ulmansky Rina Ulmansky (= 1×) peers G. Vierwinden

Countries citing papers authored by Rina Ulmansky

Since Specialization
Citations

This map shows the geographic impact of Rina Ulmansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rina Ulmansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rina Ulmansky more than expected).

Fields of papers citing papers by Rina Ulmansky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rina Ulmansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rina Ulmansky. The network helps show where Rina Ulmansky may publish in the future.

Co-authorship network of co-authors of Rina Ulmansky

This figure shows the co-authorship network connecting the top 25 collaborators of Rina Ulmansky. A scholar is included among the top collaborators of Rina Ulmansky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rina Ulmansky. Rina Ulmansky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ulmansky, Rina & Yaakov Naparstek. (2017). Protective antibodies against HSP60 for autoimmune inflammatory diseases. Clinical Immunology. 186. 63–63. 1 indexed citations
2.
Moallem, Eli, Erez Koren, Rina Ulmansky, et al.. (2016). A liposomal steroid nano-drug for treating systemic lupus erythematosus. Lupus. 25(11). 1209–1216. 26 indexed citations
4.
Ulmansky, Rina, Keren Turjeman, Moshe Baru, et al.. (2011). Glucocorticoids in nano-liposomes administered intravenously and subcutaneously to adjuvant arthritis rats are superior to the free drugs in suppressing arthritis and inflammatory cytokines. Journal of Controlled Release. 160(2). 299–305. 72 indexed citations
7.
8.
Amital, Howard, Rina Ulmansky, Fanny Szafer, et al.. (2005). Treatment with a Laminin-Derived Peptide Suppresses Lupus Nephritis. The Journal of Immunology. 175(8). 5516–5523. 66 indexed citations
9.
Naparstek, Yaakov, Fanny Szafer, Rina Ulmansky, et al.. (2004). Treatment with a laminin-derived peptide suppresses lupus nephritis. Autoimmunity Reviews. 3(7-8). 589–590. 2 indexed citations
10.
Ulmansky, Rina, Cyril J. Cohen, Fanny Szafer, et al.. (2002). Resistance to Adjuvant Arthritis Is Due to Protective Antibodies Against Heat Shock Protein Surface Epitopes and the Induction of IL-10 Secretion. The Journal of Immunology. 168(12). 6463–6469. 75 indexed citations
11.
Qureshi, Faisal, Yan Yang, Suzanne M. Jacques, et al.. (2000). Anti‐DNA Antibodies Cross‐reacting with Laminin Inhibit Trophoblast Attachment and Migration: Implications for Recurrent Pregnancy Loss in SLE Patients. American Journal of Reproductive Immunology. 44(3). 136–142. 33 indexed citations
12.
13.
Ulmansky, Rina & Yaakov Naparstek. (1995). Immunoglobulins from rats that are resistant to adjuvant arthritis suppress the disease in arthritis‐susceptible rats. European Journal of Immunology. 25(4). 952–957. 17 indexed citations
14.
Ben‐Yehuda, Arie, Linda Rasooly, Gabriel S. Breuer, et al.. (1995). The Urine of SLE Patients Contains Antibodies that Bind to the Laminin Component of the Extracellular Matrix. Journal of Autoimmunity. 8(2). 279–291. 39 indexed citations
15.
Vlodavsky, Israël, Rina Ulmansky, Ruth Atzmon, et al.. (1983). Thyrotrophin and growth hormone secretion and cell morphology in hypothyroid pituitary cells cultured on a natural extracellular matrix. European Journal of Endocrinology. 104(3). 279–286. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026